Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice

Autor:	Armenia, Daniele, Forbici, Federica, Bertoli, Ada, Berno, Giulia, Malagnino, Vincenzo, Gagliardini, Roberta, Borghi, Vanni, Gennari, William, Cicalini, Stefania, Buonomini, Annarita, Teti, Elisabetta, Lanini, Simone, Latini, Alessandra, Sarmati, Loredana, Mussini, Cristina, Andreoni, Massimo, Antinori, Andrea, Perno, Carlo F., Ceccherini-Silberstein, Francesca, Santoro, Maria M.
Zdroj:	In Journal of Global Antimicrobial Resistance September 2022 30:326-334
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect